Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/16663Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kundu, Mrinal K | - |
| dc.contributor.author | Thomas, Jacob V | - |
| dc.contributor.author | Bhat, Sujata V | - |
| dc.date.accessioned | 2013-03-29T20:33:53Z | - |
| dc.date.available | 2013-03-29T20:33:53Z | - |
| dc.date.issued | 1999-11 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/16663 | - |
| dc.description | 1299-1300 | en_US |
| dc.description.abstract | Malaria has become a serious disease throughout recorded history and the protozoan parasite of the family Plasmodidae is known to be the etiologic agent for this. The dangerously improved immunological status of various parasites (especially human malaria parasite P. falciparum) against conventional drugs such as chloroquine necessitates the development of new agents having optimum efficacy. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJC-B Vol.38B(11) [November 1999] | en_US |
| dc.title | Monoterpenic fragment analogues of Aplasmomycin as potential anti-malarials | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.38B(11) [November 1999] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 38B(11) 1299-1300.pdf | 396.39 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.